A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Sarcoma|Carcinoma|Breast Cancer|Pancreatic Cancer|Colorectal Cancer|Gastric Cancer|Liver Cancer|Lung Cancer|Gynecologic Cancer
Interventions: DRUG: Recombinant oncolytic herpes simplex virus type 1 (R130)
Sponsor: Shanghai Yunying Medical Technology
Collaborators: The Affiliated Hospital of Xuzhou Medical University